Medicine Man Technologies, Inc. (SHWZ)
- Previous Close
0.0000 - Open
0.0200 - Bid 0.2200 x --
- Ask 0.2300 x --
- Day's Range
0.0200 - 0.0200 - 52 Week Range
0.0001 - 0.6744 - Volume
1,686 - Avg. Volume
7,859 - Market Cap (intraday)
1.605M - Beta (5Y Monthly) 0.93
- PE Ratio (TTM)
-- - EPS (TTM)
-0.9400 - Earnings Date May 13, 2025 - May 19, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
2.72
Medicine Man Technologies, Inc., doing business as Schwazze, engages in the cultivation, manufacturing, distribution, and retail sale of cannabis and cannabis related products in Colorado and New Mexico. It operates through Retail, Wholesale, and Others segments. The company offers loose flower, concentrates, edibles, pre-rolls, topicals, infused beverages, and other associated cannabis products produced by cannabis vendors; and cannabis and non-cannabis products. It operates retail cannabis dispensaries under the Star Buds, Emerald Fields, Standing Akimbo, Everest Cannabis Co., and R. Greenleaf brand names. In addition, the company sells indoor gardening supplies and hydroponics through its online and retail store. Medicine Man Technologies, Inc. was incorporated in 2014 and is headquartered in Denver, Colorado.
www.schwazze.com729
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: SHWZ
View MorePerformance Overview: SHWZ
Trailing total returns as of 5/12/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SHWZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SHWZ
View MoreValuation Measures
Market Cap
1.60M
Enterprise Value
187.41M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.01
Price/Book (mrq)
0.02
Enterprise Value/Revenue
1.07
Enterprise Value/EBITDA
13.76
Financial Highlights
Profitability and Income Statement
Profit Margin
-34.12%
Return on Assets (ttm)
-1.93%
Return on Equity (ttm)
-49.97%
Revenue (ttm)
174.91M
Net Income Avi to Common (ttm)
-67.86M
Diluted EPS (ttm)
-0.9400
Balance Sheet and Cash Flow
Total Cash (mrq)
12.39M
Total Debt/Equity (mrq)
218.30%
Levered Free Cash Flow (ttm)
22.37M